Invasive fungal infections (IFI) are an emerging problem worldwide with invasive candidiasis
and candidemia responsible for the majority of cases. This is predominantly driven by the …

Fungal infections are becoming more frequent because of expansion of at-risk populations
and the use of treatment modalities that permit longer survival of these patients. Because …

To determine the epidemiology and trends of invasive fungal infections (IFIs) in France, we
analyzed incidence, risk factors, and in-hospital death rates related to the most frequent IFIs …

Every year, Candida, Aspergillus, Cryptococcus and Pneumocystis infect an estimated two
million individuals worldwide. Most are immunocompromised or critically ill. Candida is the …

Although the incidence of Pneumocystis pneumonia (PCP) has decreased since the
introduction of combination antiretroviral therapy, it remains an important cause of disease in …

The substantial decline in the Pneumocystis jirovecii pneumonia (PCP) incidence in HIV-
infected patients after the introduction of antiretroviral therapy (ART) in resource-rich settings …

Discussion The epidemiology of fungal diseases is constantly evolving. Environmental
changes, medical advancements, emerging species, and diagnostic and therapeutic …

The number of patients with non-human immunodeficiency virus (HIV) related pneumocystis
carinii pneumonia (PCP) is increasing with widespread immunosuppressive treatment. We …

Life-threatening invasive fungal infections are becoming increasingly common, at least in
part due to the prevalence of medical interventions resulting in immunosuppression …

The incidence of invasive fungal infections has risen dramatically in recent decades. Current
antifungal drugs are either toxic, likely to interact with other drugs, have a narrow spectrum …